home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GoodRx Holdings, Inc. - Class A Common Stock (NQ:GDRX)

2.330 +0.120 (+5.43%)

Official Closing Price Updated: 4:15 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GoodRx Holdings, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

GoodRx Launches New Erectile Dysfunction Subscription Service to Simplify Access and Eliminate Treatment Barriers

June 10, 2025

From GoodRx

Via Business Wire

GoodRx Launches Community Link to Offer Independent Pharmacies Cost-Plus Pricing

June 09, 2025

From GoodRx

Via Business Wire

3 Stocks Under $10 with Mounting Challenges

June 09, 2025

Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying businesses are cheap, and we advise caution as...

Via StockStory

Earnings Scheduled For May 7, 2025 ↗

May 07, 2025

Via Benzinga

The Analyst Verdict: GoodRx Holdings In The Eyes Of 4 Experts ↗

February 28, 2025

Via Benzinga

GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

June 05, 2025

From GoodRx

Via Business Wire

Healthcare Technology Stocks Q1 Recap: Benchmarking GoodRx (NASDAQ:GDRX)

May 29, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at healthcare technology stocks, starting...

Via StockStory

GoodRx to Launch Direct Contracting for Independent Community Pharmacies

May 22, 2025

From GoodRx

Via Business Wire

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

GoodRx Offers Value Proposition As Pharmacy Costs Shifts To Consumers: Analyst ↗

May 19, 2025

J.P. Morgan analyst revises outlook on GoodRx Holdings following Q1 earnings, reaffirms Overweight rating and $7 price target.

Via Benzinga

Demystifying GoodRx Holdings: Insights From 5 Analyst Reviews ↗

May 13, 2025

Via Benzinga

Why GoodRx Holdings Stock Triumphed on Thursday ↗

May 08, 2025

Via The Motley Fool

GoodRx’s (NASDAQ:GDRX) Q1 Earnings Results: Revenue In Line With Expectations, Stock Jumps 10.3%

May 07, 2025

Healthcare tech company GoodRx (NASDAQ:GDRX) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.6% year on year to $203 million. The company’s outlook for the full year was close to...

Via StockStory

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

May 07, 2025

Via Benzinga

GoodRx Reports First Quarter 2025 Results

May 07, 2025

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect

May 06, 2025

Healthcare tech company GoodRx (NASDAQ:GDRX) will be reporting results tomorrow after the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

3 Reasons to Sell GDRX and 1 Stock to Buy Instead

April 23, 2025

GoodRx’s stock price has taken a beating over the past six months, shedding 30.4% of its value and falling to $4.55 per share. This was partly driven by its softer quarterly results and may have...

Via StockStory

Topics Supply Chain

3 Healthcare Stocks with Questionable Fundamentals

April 18, 2025

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

3 of Wall Street’s Favorite Stocks Showing Warning Signs

April 17, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Healthcare Technology Stocks Q4 In Review: Hims & Hers Health (NYSE:HIMS) Vs Peers

April 17, 2025

Let’s dig into the relative performance of Hims & Hers Health (NYSE:HIMS) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call

April 09, 2025

From GoodRx Holdings, Inc.

Via Business Wire

GoodRx Introduces New E-commerce Experience for Retail Pharmacies

April 03, 2025

From GoodRx

Via Business Wire

3 Small-Cap Stocks in Hot Water

March 17, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement

March 17, 2025

From GoodRx

Via Business Wire

3 Stocks Under $10 Skating on Thin Ice

March 12, 2025

Via StockStory

GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending

March 10, 2025

From GoodRx

Via Business Wire

GoodRx (GDRX) Q4 2024 Earnings Call Transcript ↗

February 27, 2025

GDRX earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales ↗

February 27, 2025

GoodRx reported Q4 revenue of $198.6M, missing expectations. 2025 guidance projects $810M–$840M revenue and adjusted EBITDA of $270M–$286M.

Via Benzinga

GoodRx (NASDAQ:GDRX) Misses Q4 Revenue Estimates

February 27, 2025

Healthcare tech company GoodRx (NASDAQ:GDRX) missed Wall Street’s revenue expectations in Q4 CY2024, with sales flat year on year at $198.6 million. On the other hand, the company expects next...

Via StockStory

GoodRx Reports Fourth Quarter and Full Year 2024 Results

February 27, 2025

From GoodRx Holdings, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com